Concepedia

Won Seog Kim

WS

Statistics

Publications

5

Citations

210

H-Index

5

Active since

2001

Affiliations

Sungkyunkwan University(Current)

Samsung Medical Center

Institut Català d'Oncologia

Dana-Farber Cancer Institute

University of Bologna

Won Seog Kim is an author at Sungkyunkwan University specializing in gastrointestinal cancer pharmacotherapy, pharmacokinetics of anticancer agents, and oncology.

Publications per year

2001–2025

5

Publications

5

Phase II Study of High-Dose Lovastatin in Patients with Advanced Gastric Adenocarcinoma

Won Seog Kim, Myung Min Kim, Hae Jin Choi et al. · Investigational New Drugs · 2001 · 138 citations

, , +11

Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors

Jason J. Luke, David J. Pinato, Dejan Juric et al. · Journal for ImmunoTherapy of Cancer · 2025 · 32 citations · Full text

, , +17

CHRONOS-4: phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma

Pier Luigi Zinzani, Huaqing Wang, Jifeng Feng et al. · Blood Advances · 2024 · 16 citations · Full text

, , +15

Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma

Thomas E. Witzig, Lubomir Sokol, Won Seog Kim et al. · Blood Advances · 2024 · 12 citations · Full text

, , +17

Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial

Nirav N. Shah, Michael Wang, Lindsey E. Roeker et al. · Haematologica · 2024 · 12 citations · Full text

, , +14

1–5 of 5